BOSENTAN RAN bosentan (as monohydrate) 125 mg film-coated tablet blister pack

Страна: Австралія

мова: англійська

Джерело: Department of Health (Therapeutic Goods Administration)

Активний інгредієнт:

bosentan monohydrate, Quantity: 129.083 mg

Доступна з:

Sun Pharma ANZ Pty Ltd

ІПН (Міжнародна Ім'я):

bosentan monohydrate

Фармацевтична форма:

Tablet, film coated

Склад:

Excipient Ingredients: pregelatinised maize starch; magnesium stearate; maize starch; povidone; sodium starch glycollate type A; glycerol dibehenate; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red; ethylcellulose

Адміністрація маршрут:

Oral

Одиниць в упаковці:

56, 60

Тип рецепту:

(S4) Prescription Only Medicine

Терапевтичні свідчення:

Bosentan is indicated for the treatment of,? idiopathic pulmonary arterial hypertension,? familial pulmonary arterial hypertension,? pulmonary arterial hypertension associated with scleroderma or,? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including Eisenmenger?s physiology,in patients with WHO functional Class II, III or IV symptoms

Огляд продуктів:

Visual Identification: The 125mg film-coated tablets are light peach to peach colored, oval shaped, biconvex & debossed with '125' on one side & plain on the other side; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Статус Авторизація:

Licence status A

Дата Авторизація:

2016-07-11